• DiSQ is a new qualification and validation software for pharmaceutical processes
  • Workshop on Paperless Validation and Digitization, key in optimizing the validation process

Telstar will participate at FarmaForum 2022 (Madrid, October 5-6, 2022), the congress for the pharmaceutical, biotechnology, cosmetics, and laboratory technology industries. Within the framework of this event, Marcel Porta, Consultancy Division Manager at Telstar in Spain, will lead a workshop entitled “Paperless Validation: a need in optimizing the validation process”. The expert will address the impact of new smart applications in commissioning and qualification using digital documents instead of traditional paper in the optimization of the life cycle of the validation and verification process and risk management. This workshop will take place on October 5th at 10am.

Validation is an essential process in pharmaceutical production as it provides documented evidence that a system or process complies with GMP/FDA regulatory requirements, while endorsing the correct manufacture of products at the required quality level and with a safety guarantee. The life cycle of the validation of a pharmaceutical process involves a long tedious flow of editing, approval and execution that consumes time and vast amounts of paper, in addition to the process of subsequent management of this documentation, its archiving and subsequent recovery, wasting human, economic and environmental resources. The use of database applications designed for electronic and digital management optimizes the entire validation life cycle. Telstar DiSQ has been designed to facilitate project management, foster standardization, guarantee traceability, ensure compliance with Data Integrity concepts, provide real-time information on the status of the different documents, and allow electronic execution and automatic generation of queries and reports on the validation status.

The speaker

Marcel Porta is Consulting Division Manager at Telstar in Spain, covering the areas of Commissioning and Qualification, Validation of Computerized Systems, Audits, Preclinical/Clinical Support and Quality Assurance. He has a master’s degree in Superior Industrial Engineering from the UPC (Polytechnic University of Catalonia), with PhD studies in ​​Environmental Radioactivity and a master’s degree in Biomedical Engineering from the UB (University of Barcelona). He worked for more than 10 years in the pharmaceutical multinational Alcon, from head of Validations to representative of the Management in Quality matters. In 2013 he joined Telstar.

Telstar: booth D32 – E17

Telstar will also participate in FarmaForum 2022 as an exhibitor (Stand D32 – E17).